RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
RAPT Therapeutics (NASDAQ: RAPT), a clinical-stage biopharmaceutical company specializing in immunology-based therapies, has announced its participation in four major investor conferences in September 2025.
The company will present at the Wells Fargo Healthcare Conference (Sept 3), Cantor Global Healthcare Conference (Sept 4), H.C. Wainwright Global Investment Conference (Sept 9), and Stifel Virtual Immunology & Inflammation Forum (Sept 15). All presentations will be accessible via webcast on the company's investor relations website.
RAPT Therapeutics (NASDAQ: RAPT), azienda biofarmaceutica in fase clinica specializzata in terapie immunologiche, ha annunciato la sua partecipazione a quattro importanti conferenze per investitori nel mese di settembre 2025.
L'azienda presenterà al Wells Fargo Healthcare Conference (3 set), al Cantor Global Healthcare Conference (4 set), all'H.C. Wainwright Global Investment Conference (9 set) e allo Stifel Virtual Immunology & Inflammation Forum (15 set). Tutte le presentazioni saranno disponibili in webcast sul sito investor relations della società.
RAPT Therapeutics (NASDAQ: RAPT), una compañía biofarmacéutica en fase clínica especializada en terapias basadas en la inmunología, ha anunciado su participación en cuatro importantes conferencias para inversores en septiembre de 2025.
La compañía presentará en el Wells Fargo Healthcare Conference (3 de sept), en el Cantor Global Healthcare Conference (4 de sept), en el H.C. Wainwright Global Investment Conference (9 de sept) y en el Stifel Virtual Immunology & Inflammation Forum (15 de sept). Todas las presentaciones estarán disponibles por webcast en la página de relaciones con inversores de la compañía.
RAPT Therapeutics (NASDAQ: RAPT), 면역 기반 치료제를 전문으로 하는 임상 단계의 바이오제약 회사가 2025년 9월에 열리는 네 곳의 주요 투자자 컨퍼런스에 참여한다고 발표했습니다.
회사는 Wells Fargo Healthcare Conference(9월 3일), Cantor Global Healthcare Conference(9월 4일), H.C. Wainwright Global Investment Conference(9월 9일), Stifel Virtual Immunology & Inflammation Forum(9월 15일)에서 발표할 예정입니다. 모든 발표는 회사 투자자 관계 웹사이트를 통해 웹캐스트로 시청할 수 있습니다.
RAPT Therapeutics (NASDAQ: RAPT), une société biopharmaceutique en phase clinique spécialisée dans les thérapies basées sur l'immunologie, a annoncé sa participation à quatre grandes conférences investisseurs en septembre 2025.
La société présentera au Wells Fargo Healthcare Conference (3 sept.), au Cantor Global Healthcare Conference (4 sept.), au H.C. Wainwright Global Investment Conference (9 sept.) et au Stifel Virtual Immunology & Inflammation Forum (15 sept.). Toutes les présentations seront accessibles en webcast sur le site des relations investisseurs de la société.
RAPT Therapeutics (NASDAQ: RAPT), ein biopharmazeutisches Unternehmen in der klinischen Entwicklungsphase, das sich auf immunologiegestützte Therapien spezialisiert hat, gab seine Teilnahme an vier bedeutenden Investorenkonferenzen im September 2025 bekannt.
Das Unternehmen wird auf der Wells Fargo Healthcare Conference (3. Sept.), der Cantor Global Healthcare Conference (4. Sept.), der H.C. Wainwright Global Investment Conference (9. Sept.) und dem Stifel Virtual Immunology & Inflammation Forum (15. Sept.) präsentieren. Alle Präsentationen sind per Webcast auf der Investor-Relations-Website des Unternehmens verfügbar.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that members of the RAPT management team will participate in the following investor conferences in September:
- 2025 Wells Fargo Healthcare Conference – Fireside chat on Wednesday, September 3, 2025 at 12:45 p.m. ET
- Cantor Global Healthcare Conference 2025 – Fireside chat on Thursday, September 4, 2025 at 1:00 p.m. ET
- H.C. Wainwright 27th Annual Global Investment Conference – Fireside chat on Tuesday, September 9, 2025 at 9:00 a.m. ET
- Stifel 2025 Virtual Immunology & Inflammation Forum – Presentation on Monday, September 15, 2025 at 9:30 a.m. ET
To access the live webcasts or subsequent archived recordings of the fireside chats and presentation, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.
About RAPT Therapeutics, Inc.
RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases. Utilizing our deep and proprietary expertise in immunology, we develop novel therapies that are designed to modulate the critical immune responses underlying these diseases.
RAPT Investor Contact:
Sylvia Wheeler
swheeler@wheelhouselsa.com
RAPT Media Contact:
Aljanae Reynolds
areynolds@wheelhouselsa.com
FAQ
When is RAPT Therapeutics presenting at the Wells Fargo Healthcare Conference 2025?
How can investors access RAPT Therapeutics' conference presentations in September 2025?
Which investor conferences will RAPT Therapeutics attend in September 2025?
What time is RAPT Therapeutics presenting at the Stifel 2025 Virtual Immunology & Inflammation Forum?
